Aptevo Therapeutics (APVO) investors approve 2026 meeting agenda
Rhea-AI Filing Summary
Aptevo Therapeutics Inc. (APVO) reported the results of its 2026 Annual Meeting of Stockholders held on August 21, 2026. A quorum was present and four proposals were voted on.
Stockholders elected two directors, Zsolt Harsanyi, Ph.D. and Barbara Lopez Kunz, to the board to serve until the 2029 Annual Meeting and until their successors are elected and qualified. Baker Tilly US, LLP was approved as independent registered public accounting firm for the year ending December 31, 2026. Stockholders approved, on an advisory basis, the compensation of the company’s named executive officers for 2025, and also approved Aptevo’s Fourth Amended and Restated 2018 Stock Incentive Plan.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Zsolt Harsanyi, Ph.D.: 216,997
Votes for Barbara Lopez Kunz: 211,050
Votes for auditor ratification: 606,661
+4 more
7 metrics
Votes for Zsolt Harsanyi, Ph.D.
216,997
Election as director to serve until the 2029 Annual Meeting
Votes for Barbara Lopez Kunz
211,050
Election as director to serve until the 2029 Annual Meeting
Votes for auditor ratification
606,661
For ratification of Baker Tilly US, LLP as auditor for 2026
Votes for 2025 executive compensation (advisory)
165,615
For the non-binding advisory vote on named executive officer compensation
Votes for Fourth Amended and Restated 2018 Stock Incentive Plan
166,484
For approval of the stock incentive plan
Broker non-votes on executive compensation proposal
402,427
Broker non-votes for the 2025 executive compensation advisory proposal
Broker non-votes on stock incentive plan proposal
402,427
Broker non-votes for the Fourth Amended and Restated 2018 Stock Incentive Plan proposal
Key Terms
broker non-votes, independent registered public accounting firm, non-binding advisory vote, Fourth Amended and Restated 2018 Stock Incentive Plan
4 terms
broker non-votes financial
"FOR | AGAINST | ABSTAIN | BROKER NON-VOTES 165,615 |"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"The appointment of Baker Tilly US, LLP to serve as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
non-binding advisory vote financial
"The non-binding advisory vote on the compensation paid to our named executive officers"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
Fourth Amended and Restated 2018 Stock Incentive Plan financial
"The Aptevo Therapeutics Inc. Fourth Amended and Restated 2018 Stock Incentive Plan was approved"
FAQ
What did APVO stockholders decide at the 2026 Annual Meeting?
Stockholders elected two directors to serve until 2029, ratified Baker Tilly US, LLP as independent auditor for 2026, approved on an advisory basis 2025 executive compensation, and approved the Fourth Amended and Restated 2018 Stock Incentive Plan.
Who was elected to Aptevo Therapeutics Inc. (APVO)’s board in 2026?
Zsolt Harsanyi, Ph.D. and Barbara Lopez Kunz were elected as directors. They will serve until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified.
Was the auditor ratified by APVO stockholders for 2026?
Yes. Stockholders approved Baker Tilly US, LLP as Aptevo’s independent registered public accounting firm for the year ending December 31, 2026, with 606,661 votes for, 28,847 against, and 1,370 abstentions.
How did APVO stockholders vote on 2025 executive compensation?
The advisory vote on 2025 executive compensation was approved, receiving 165,615 votes for, 24,031 against, and 44,805 abstentions, with 402,427 broker non-votes.
Did APVO’s Fourth Amended and Restated 2018 Stock Incentive Plan get approved?
Yes. The Fourth Amended and Restated 2018 Stock Incentive Plan was approved with 166,484 votes for, 64,248 against, and 3,719 abstentions, and 402,427 broker non-votes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
